Clinical Trial Update: Everolimus TDM to Predict Long Term Toxicity

View source ↗

Summary

A clinical trial evaluates whether therapeutic drug monitoring of everolimus can predict long-term toxicity in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Neuroendocrine Tumor
• Neuroendocrine Tumor of the Lung
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Breast Cancer, Renal Cell Carcinoma | Status: UNKNOWN